logo

Publications (since 2010)

ORIGINAL PAPERS IN PEER REVIEWED JOURNALS

  1. Basu N, Luqmani R, Bajema I, Bo Baslund, Bley T, Boers M, Brogan P, Calabrese L, Cid M, Cohen-Tervaert JW, Flores-Suarez LF, Fujimoto S, Gross W, de Groot K, Guillevin L, Hatemi G, Hauser T, Jayne DRW, Jennete C, Kallenberg CGM, Kobayashi S, Little M, Mahr A, McLaren J, Merkel PA, Ozen S, Puechal X, Rasmussen N, Alan Salama A, Salvarani C, Savage CO, Scott DGI, Segelmark M, Specks U, Sunderkotter C, Suzuki K, Tesar V, Wiik A, Yazici H, Watts RA. EULAR/ACR endorsed points to consider in the development of classification and diagnostic criteria in systemic vasculitides. Ann Rheum Dis 2010 ; 69: 1744-50.
  2. Ravindran V, Watts RA. Pulmonary haemorrhage in ANCA-associated vasculitis. Rheumatology 2010; 49:1410-7
  3. Niederer HA, Willcocks LC, Rayner TF, Yang W, Lau YL, Williams TN, Scott JA, Urban BC, Peshu N, Dunstan SJ, Hien TT, Phu NH, Padyukov L, Gunnarsson I, Svenungsson E, Savage CO, Watts RA, Lyons PA, Clayton DG, Smith KG. Copy number, linkage disequilibrium and disease association in the FCGR locus. Hum Mol Genet. 2010 Jun 10. Click to view
  4. Watts RA, Snell J. Service redesign. Action points for arthritis care. Health Services Journal 2010; 120: 22-3.
  5. Guerry M_J CJ, Brogan P, Bruce IN, D’Cruz DP, Harper L, Luqmani RA, Pusey CD, Salama AD, Scott DGI, Savage COS, Watts RA, Jayne DRW. Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody associated vasculitis. Rheumatology (2012) 51(4): 634-643 doi:10.1093/rheumatology/ker150. Click to view
  6. Heijl C, Harper L, Flossman O, Stuecker I, Scott DGI, Watts RA, Hoeglund P, Westman K, Mahr A. Incidence of malignancy in patients treated for ANCA-associated vasculitides: follow up data from clinical trails of the European Vasculitis Study Group (EUVAS). Ann Rheum Dis. 2011 Aug;70(8):1415-21.
  7. Fujimoto S, Watts RA, Kobayashi S, Suzuki K, Jayne DRW, Scott GDI, Hashimoto H, Nunoi H. Comparison of the epidemiology of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis between Japan and UK. Rheumatology (2011) 50(10): 1916-1920 first published online July 28, 2011 doi:10.1093/rheumatology/ker205. Click to view.
  8. Candy EA, Farewell D, Jerosch-Herald, C, Watts RA; Lee Shepstone L, Stephenson RC. The effect of a high density foam seating wedge on back pain intensity when used by 14-16 year old school students: A randomised controlled trial. Physiotherapy 2011 (in press).
  9. Fuchs M, Briel M, Daikeler T, Walker UA, Rasch H, Berg S, Ng QT, Kesten F, Hess C, Jayne DR, Kötter I, Blockmans D, Cid MC, Lamprecht P, Salvarani C , Karageorgaki Z, Watts RA, Luqmani R, Müller-Brand J, Tyndall A, Walter MA. The impact of 18FDG-PET on the management of patients with suspected large vessel vasculitis. Eur J Nucl Med Mol Imaging 2012; 39: 344-53.
  10. Harper L, Morgan M, Walsh M, Westmann K, Flossmann O, Tesar V, Vanhille, de Groot PK, Luqmani R, Flores-Suarez LF, Watts RA, Hoglund P, Pusey C, Bruchfeld A, Rassmussen N, Savage C, Jayne DRW; on behalf of EUVAS investigators. Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated Vasculitis. A European, multicenter randomised controlled trial – Long term Follow up. Ann Rheum Dis 2011;
  11. Watts RA, Mooney J, Skinner J, Scott DGI, MacGregor AJ. The contrasting epidemiology of granulomatosis with polyangiitis (Wegener’s granulomatosis) and microscopic polyangiitis. Rheumatology first published online January 17, 2012 doi:10.1093/rheumatology/ker454. Click to view .
  12. Lyons PA, Rayner TF, Trivedi, S., Holle, JU, Watts, RA, Jayne DRW et al. Genetically Distinct Subsets within ANCA-Associated Vasculitis. New Engl J Med 2012 in press